Stockreport

Lineage Cell Therapeutics Presents New OpRegen® Data at American Academy of Ophthalmology Annual Meeting

Lineage Cell Therapeutics, Inc.  (LCTX) 
PDF Treatment with OpRegen Continues to be Well Tolerated with Increased Visual Acuity Observed in Cohort 4 Patients CARLSBAD, Calif.--(BUSINESS WIRE)--Lineage Cell Thera [Read more]